147 related articles for article (PubMed ID: 9600110)
21. A novel pre-B acute lymphoblastic leukemia cell line with chromosomal translocation between p16(INK4A)/p15(INK4B) tumor suppressor and immunoglobulin heavy chain genes: TGFbeta/IL-7 inhibitory signaling mechanism.
Urashima M; Hoshi Y; Sugimoto Y; Kaihara C; Matsuzaki M; Chauhan D; Ogata A; Teoh G; DeCaprio JA; Anderson KC
Leukemia; 1996 Oct; 10(10):1576-83. PubMed ID: 8847892
[TBL] [Abstract][Full Text] [Related]
22. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
Flores JF; Walker GJ; Glendening JM; Haluska FG; Castresana JS; Rubio MP; Pastorfide GC; Boyer LA; Kao WH; Bulyk ML; Barnhill RL; Hayward NK; Housman DE; Fountain JW
Cancer Res; 1996 Nov; 56(21):5023-32. PubMed ID: 8895759
[TBL] [Abstract][Full Text] [Related]
23. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies.
Herman JG; Civin CI; Issa JP; Collector MI; Sharkis SJ; Baylin SB
Cancer Res; 1997 Mar; 57(5):837-41. PubMed ID: 9041182
[TBL] [Abstract][Full Text] [Related]
24. BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma.
Monni O; Joensuu H; Franssila K; Klefstrom J; Alitalo K; Knuutila S
Blood; 1997 Aug; 90(3):1168-74. PubMed ID: 9242549
[TBL] [Abstract][Full Text] [Related]
25. Establishment of a near-triploid human B-cell lymphoma cell line with t(14;18) and a p53 gene point mutation.
Yamaguchi H; Inokuchi K; Hanawa H; Tanosaki S; Shinozawa I; Matuoka H; Dan K
Br J Haematol; 1999 Jun; 105(3):764-7. PubMed ID: 10354143
[TBL] [Abstract][Full Text] [Related]
26. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
Herman JG; Jen J; Merlo A; Baylin SB
Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
[TBL] [Abstract][Full Text] [Related]
27. Alterations of p16INK4A and p15INK4B genes in gastric carcinomas.
Lee YY; Kang SH; Seo JY; Jung CW; Lee KU; Choe KJ; Kim BK; Kim NK; Koeffler HP; Bang YJ
Cancer; 1997 Nov; 80(10):1889-96. PubMed ID: 9366289
[TBL] [Abstract][Full Text] [Related]
28. De novo acute B cell leukemia/lymphoma with t(14;18).
Stamatoullas A; Buchonnet G; Lepretre S; Lenain P; Lenormand B; Duval C; Callat MP; Gaulard P; Bastard C; Tilly H
Leukemia; 2000 Nov; 14(11):1960-6. PubMed ID: 11069032
[TBL] [Abstract][Full Text] [Related]
29. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
30. Expression of cell cycle regulatory genes in chronic myelogenous leukemia.
Iolascon A; Della Ragione F; Giordani L; Serra A; Saglio G; Faienza MF
Haematologica; 1998 Sep; 83(9):771-7. PubMed ID: 9825572
[TBL] [Abstract][Full Text] [Related]
31. Molecular features of primary mediastinal B-cell lymphoma: involvement of p16INK4A, p53 and c-myc.
Scarpa A; Moore PS; Rigaud G; Inghirami G; Montresor M; Menegazzi M; Todeschini G; Menestrina F
Br J Haematol; 1999 Oct; 107(1):106-13. PubMed ID: 10520030
[TBL] [Abstract][Full Text] [Related]
32. p16INK4A and p15INK4B gene deletions in primary leukemias.
Haidar MA; Cao XB; Manshouri T; Chan LL; Glassman A; Kantarjian HM; Keating MJ; Beran MS; Albitar M
Blood; 1995 Jul; 86(1):311-5. PubMed ID: 7795238
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
34. Establishment of a human cell line (SKI-DLCL-1) with a t(1;14)(q21;q32) translocation from the ascites of a patient with diffuse large cell lymphoma.
Goy A; Gilles F; Remache Y; Filippa D; Portlock CS; Jhanwar SC; Zelenetz AD
Leuk Lymphoma; 2001 Jan; 40(3-4):419-23. PubMed ID: 11426565
[TBL] [Abstract][Full Text] [Related]
35. [BCL-2 in primary central nervous system lymphomas. Immunohistochemistry and molecular biology].
Buccoliero AM; Castiglione F; Caldarella A; Rossi Degl'Innocenti D; Taddei A; Ammannati F; Mennonna P; Taddei GL
Pathologica; 2004 Oct; 96(5):425-9. PubMed ID: 15688978
[TBL] [Abstract][Full Text] [Related]
36. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
37. p53 and p16INK4A mutations during the progression of glomus tumor.
Güran S; Tali ET
Pathol Oncol Res; 1999; 5(1):41-5. PubMed ID: 10079377
[TBL] [Abstract][Full Text] [Related]
38. Translocation (3;14)(q27;q11): a new variant translocation in a patient with non-Hodgkin's lymphoma of B-cell type with BCL6 rearrangement.
Takahashi N; Miura I; Ohshima A; Utsumi S; Nimura T; Hashimoto K; Cyubachi A; Saitoh M; Enomoto K; Miki T; Hirosawa S; Miura A
Cancer Genet Cytogenet; 1996 Aug; 90(1):49-53. PubMed ID: 8780747
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas.
Malumbres M; Pérez de Castro I; Santos J; Meléndez B; Mangues R; Serrano M; Pellicer A; Fernández-Piqueras J
Oncogene; 1997 Mar; 14(11):1361-70. PubMed ID: 9178896
[TBL] [Abstract][Full Text] [Related]
40. A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
Yufu Y; Goto T; Choi I; Uike N; Kozuru M; Ohshima K; Taniguchi T; Motokura T; Yatabe Y; Nakamura S
Cancer; 1999 Apr; 85(8):1750-7. PubMed ID: 10223569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
